Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 14, 2016
Vetter has announced that its new clinical syringe line has already manufactured for its customers a double digit number of batches for use in early clinical trials. The line is part of growth expansion activities that have been undertaken at its ...
read more
Onyx Scientific has made a strategic investment to position the company for a commercial API license.
read more
Thursday, November 15, 2012
Pharmaceutical Product Development, LLC (PPD) has signed a license agreement to use Tessella and Berry Consultants’ FACTSTM software to create a more flexible, intuitive approach for designing both adaptive and fixed trials.
read more
Thursday, October 17, 2024
Adimab, LLC announced the appointment of Aaron Sato, Ph.D., to the newly created position of Chief Strategy Officer.
read more
Vetter has been named Best Managed Company in its anniversary year for the sixth time in a row. The award demonstrates how Vetter pursues its strategic goals in a focused and action-driven manner. The jury recognizes the company’s long-term thinking ...
read more
Bayer announced the Stivarga® arm of the platform trial GBM AGILE has opened enrollment for patients with newly diagnosed and recurrent glioblastoma.
read more
Thursday, August 04, 2022
Evonik is building a new cGMP facility to manufacture lipids for clinical development and launch of innovative medicines. The new cGMP lipid launch facility is located in Hanau, Germany and will provide customers with smaller batch sizes of lipids as...
read more
Catawba Research, a full-service contract research organization (CRO) announced Andy Silverman, Ph.D., has joined its leadership team as its chief operating officer (COO).
read more
Wednesday, December 13, 2017
Samsung BioLogics has been licensed by the Europe’s EMA for the first monoclonal antibody Drug Substance at its second plant.
read more
Thursday, November 01, 2018
PMI BioPharma Solutions announced that David Sunseri, PhD has been appointed Chief Executive Officer effective August 2018.
read more
Wednesday, November 28, 2018
Ajinomoto Bio-Pharma Services presented data at the World ADC Summit in San Diego this month describing a proprietary site-selective bioconjugation technology, AJICAP.
read more
Vectura Group plc announced it has signed an agreement with Incannex Healthcare Limited, an Australian cannabinoid medicines development company, to provide pre-clinical development services for IHL-216A, Incannex’s proprietary inhaled drug product ...
read more
Wednesday, April 06, 2022
INCOG BioPharma Services, an Indiana-based contract development and manufacturing organization (CDMO) has completed the construction of its cleanroom production area within the new 90,000ft2 biopharma manufacturing site.
read more
Seneca Biopharma announced the completion of its new cell manufacturing facility in Suzhou, China.
read more
ISA announced plans to initiate a trial for the combination of ISA101b and Libtayo in oropharyngeal cancer.
read more